Efficacy of Structured Insulin Order
1 other identifier
interventional
128
1 country
1
Brief Summary
The purpose of this study is to determine whether an electronic order template for basal-bolus insulin will improve mean blood glucose in hospitalized general medical patients with poorly controlled type 2 diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable type-2-diabetes-mellitus
Started Mar 2009
Shorter than P25 for not_applicable type-2-diabetes-mellitus
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
May 24, 2010
CompletedFirst Posted
Study publicly available on registry
May 26, 2010
CompletedMay 26, 2010
May 1, 2010
3 months
May 24, 2010
May 24, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean blood Glucose
6 days
Secondary Outcomes (2)
rates of glucose values less than 60 mg/dl or less than 40 mg/dl
6 days
rate of use of sliding scale insulin
6 days
Study Arms (2)
Ordering template and education
ACTIVE COMPARATORInternal medical residents who were asked to use the insulin order template and received education about basal-bolus insulin ordering.
Education
ACTIVE COMPARATORInternal medical residents who received education about basal-bolus insulin ordering.
Interventions
Using electronic insulin order template for basal-bolus insulin and education
Eligibility Criteria
You may qualify if:
- Blood glucose less than 60 mg/dl or greater than 180 mg/dl during hospital stay
You may not qualify if:
- Diagnosis of Type 1 Diabetes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Enrico Cagliero, M.D.
Massachusetts General Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 24, 2010
First Posted
May 26, 2010
Study Start
March 1, 2009
Primary Completion
June 1, 2009
Study Completion
June 1, 2009
Last Updated
May 26, 2010
Record last verified: 2010-05